Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial ...

Clario's Advanced AI-Powered Platform Streamlines Clinical Document Processing to Facilitate Faster Drug Development Timelines PHILADELPHIA, April 16, 2025 /PRNewswire/ -- Clario, a leading provider ...

Life sciences giant Thermo Fisher Scientific has agreed to acquire clinical trials software company Clario for a consideration of up to $9.4bn.

Data security is one of the highest priorities when managing clinical trials. Clario's new Federated Identity Management (FIM) System means clients now have the option to use their own trusted login ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

Clario's third annual ESG report for the calendar year 2023 highlights advancements in responsible artificial intelligence (AI), employee program investments, and ambitious science-based ...

PHILADELPHIA, April 16, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced a multi-year agreement with Amazon Web Services (AWS) ...